Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing government health coverage starting Oct. 1.

About half of rural voters identify with MAHA movement, but most said President Trump’s health care policies have not benefited their communities, according to a new poll.

Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.

STAT trust-in-science reporter Nick Florko speaks with sociologist Jennifer Reich about why some parents hesitate to vaccinate their children, and why dismissing their concerns can be counter-productive. Florko and Reich explore why parents may delay v...

YouTube video by STAT

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

STAT trust-in-science reporter Nick Florko speaks with sociologist Jennifer Reich about why some parents hesitate to vaccinate their children, and why dismissing their concerns can be counter-productive. Florko and Reich explore why parents may delay v...

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.

The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care in federal prison.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Our finding was remarkable because it had remained hidden within one of the best-studied organs in medical history.

“Arguing over whether someone died ‘with’ or ‘of’ a disease gets us stuck on the last thing that happened.” write two Unbiased Science scientists.

President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.

The Readout LOUD is going international this week with a dispatch from Shanghai, along with notes on the FDA's Overton era.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

Advanced Research Projects Agency for Health is planning a total-lifespan research project on autism: A Q&A with its leader, Russell Shilling.

Virtually all of the 175,000 public comments on a 2022 FDA proposal to ban menthol cigarettes were form letters, most echoing tobacco industry talking points.

At least five candidates are in the running to become the next director-general of the WHO, a job that will come with extraordinary challenges.

Senators focused on asking Overton about vaccines, abortion, and vapes.

President Trump and his aides boasted that every U.S. state wanted to participate in a drug pricing initiative through Medicaid. Several states said they weren't sure yet.

Klomp, a behind-the-scenes HHS power player, is likely to be confirmed as second-in-command to RFK Jr.

What to know about Dr. Heidi Overton, Trump's pick to run the FDA, including her medical background and career trajectory.

What to know about Dr. Heidi Overton, Trump's pick to run the FDA, including her medical background and career trajectory.

Heidi Overton, Trump's pick for FDA head, will face questions at a Senate hearing. Follow along with our live blog.

A planned EO that would have greatly enhanced White House influence over grants at the NIH is “looking dead,” a source said.

Exclusive: Heidi Overton plans to tell senators she will speed up biomedical research, working with FDA staff.

A conversation on the future of biosimilars as competition grows and policy continues to evolve.

Medicines for osteoporosis are grabbing the attention of the pharma industry, which has been incentivized by a long-awaited regulatory change.

“The maternal mental health needs of women like me have been badly underprioritized in American society,” writes Meg LeDuc.

Some health insurers push back on a Medicare proposal that would disrupt how doctors can bill for remotely monitoring patients' health.

Other private equity-owned hospital chains have collapsed in recent years, so the stakes are high for Quorum.

Two former FDA commissioners: Heidi Overton is the right pick in a difficult moment.

Why an influential GOP health policy expert still backs $1 trillion in Medicaid cuts — and which policy target is next.

“Researchers must seize this opportunity to examine how social media — and its regulation — impacts teenagers,” writes Wellcome’s Camilla Iannone.

Several members of Congress voiced strong opposition about a reported plan to create a panel of political appointees to sign off on NIH grants

The race between Amy Acton and Vivek Ramaswamy could be the election’s most direct test of where the heartland stands on health care and the pandemic.

YouTube video by STAT

How one state's governor's race is a test of whether Robert F. Kennedy Jr.'s MAHA movement has an enduring political draw.